LDS/Medical Tests/Praxis™ Extended RAS Panel

Praxis™ Extended RAS Panel

The Praxis™ Extended RAS Panel is an FDA approved, qualitative, in vitro diagnostic test for the detection of 56 specific mutations in RAS genes [KRAS (exons 2, 3, and 4) and NRAS (exons 2, 3, and 4)] in colorectal cancer (CRC). These mutations are known to affect the efficacy of Vectibix (Panitumumab) for the treatment of metastatic colorectal cancer (mCRC). Vectibix is a monoclonal antibody directed against the epidermal growth factor receptor (EGFR). Although, monoclonal antibodies such as cetuximab and panitumumab, are used as a targeted therapy for CRC patients, these drugs are expensive and potentially toxic. Therefore, only patients who are likely to respond should be selected for antibody-based therapy to prevent unnecessary drug toxicity and associated expense.

Approximately 53% of patients with mCRC have RAS mutations, with 42.0% having KRAS exon 2 mutations and 11% having KRAS non-exon 2 and NRAS mutations. RAS mutations constitutively activate the RAS-RAF-ERK pathway and confer resistance to cetuximab and panitumumab. Therefore, patients whose tumors contain RAS mutations should not be treated with anti-EGFR mAbs.

  • To detect RAS gene mutations in colorectal cancer and identify patients who are RAS mutation negative and therefore eligible for anti-EGFR mAB therapy

Negative:

no Praxis Extended RAS Panel mutations are detected.

Positive:

Praxis Extended RAS Panel mutation is detected (KRAS or NRAS gene)

Normal - no Praxis Extended RAS Panel mutations

Targeted DNA Sequencing, Next generation sequencing.

Formalin fixed paraffin embedded (FFPE) tissue samples.

Stability

FFPE samples are stable at room temperature for longer. 

 

Colorectal cancer multi gene panel, Microsatellite Instability (MSI), Colorectal biopsy, Colorectal FNA cytology.
5-8 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login